The media won’t tell you about Trump’s new deal

Dear Reader, 

Officially, the mainstream media has nothing to say.

Check CNN... MSNBC... even the financial outlets like Bloomberg... and you'll find practically zero coverage.

Even though this could be the most lucrative income opportunity of the 21st century.

I’m calling it "President Trump's real estate deal for America"... 

That's because it allows regular Americans to "piggyback" off federal land and get paid... 

Now, even though the mainstream outlets largely refuse to acknowledge this... 

A few words from my friend President Trump himself tell you all you need to know... 

He said, "This is your treasure, and you, the American people, are entitled to share in the riches."

Incredible. 

So, if you've been kept in the dark about this opportunity, like most Americans... 

You need to get the facts fast. 

Click here for the full reveal on President Trump's "real estate deal for America."

Regards,

Brad Thomas
Editor, Wide Moat Research


 
 
 
 
 
 

Tuesday's Exclusive News

This NVIDIA Partnership Shows How Big AI Can Really Get

Authored by Thomas Hughes. Date Posted: 1/12/2026.

NVIDIA chip paired with Lilly branding, symbolizing AI-driven drug discovery and biotech innovation.

Quick Look

  • NVIDIA’s valuation remains compelling in early 2026, with long-term forecasts suggesting potential gains of 200% to 500% over the next decade.
  • New partnerships—including a $1 billion AI drug discovery initiative with Eli Lilly—highlight NVIDIA’s expanding role beyond GPUs.
  • Analysts cite robotics and accelerated AI adoption as key 2026 growth drivers, with earnings and guidance expected to confirm bullish sentiment.

NVIDIA's (NASDAQ: NVDA) stock is heating up again as its long-term outlook expands and the valuation looks increasingly compelling. Trading at roughly 40x earnings in early 2026, the market appears to be underestimating what is becoming an overly cautious forecast.

Driven by NVIDIA's move beyond GPUs, the company—not just its hardware—is becoming critical to business advancement across industries.

The gold story that no one's telling (Ad)

Gold Headed Above $5,000 per Ounce in 2026? Here's How to Play It...

With so many strange events happening across the economy (consumer confidence plummeting, credit-card delinquencies soaring, and more), it's no wonder the richest investors are loading up on gold. But what you might not realize is that there's a much better way to profit from rising gold prices - WITHOUT ever touching an ETF, mining stock, or even bullion.

Get the full details here.tc pixel

Right now, the stock is valued at only eight times its 2035 earnings forecast, implying investors could see as much as a 200% gain over the next decade just to match the S&P 500. If NVIDIA continues to command a premium—arguably justified by its role in the AI ecosystem—gains could reach the 300% to 500% range before leveling off.

NVIDIA chart shows a strong uptrend holding above key moving averages, with momentum indicators suggesting continued bullish support.

NVIDIA and Eli Lilly Invest $1 Billion in Accelerated Drug Discovery

The latest evidence of NVIDIA's expanding role in the AI ecosystem is in the details of its partnership with Eli Lilly (NYSE: LLY). First teased at CES, the collaboration aims to build an AI supercomputer to accelerate drug discovery, manufacturing processes, applications and other health-related insights. The initiative describes a closed-loop system where AI-generated discoveries support physicians, and physicians using AI-enabled experimentation tools help refine the AI models—together accelerating and disrupting the drug discovery industry.

This is not a small market. Drug discovery was worth roughly $105 billion at the end of 2025 and is expected to grow at a high-single-digit — nearly 10% — compound annual growth rate for the foreseeable future. Today, AI-enabled discovery represents less than 20% of that market but is projected to expand roughly sixfold within the next eight years. More significantly, drug discovery is a gateway to the even more lucrative drug production and sales market, which is worth more than $550 billion in the U.S. alone.

Other sectors where NVIDIA has entrenched itself include machinery and heavy equipment, automotive, telecommunications, energy, retail and robotics. Work with Caterpillar (NYSE: CAT) supports autonomous operation, management and deployment of fleet equipment, while Archer Aviation (NYSE: ACHR), a key player in eVTOL aircraft, is integrating NVIDIA's Thor IGX platform into its aircraft. Thor is a scalable, industrial-grade AI platform that enables the complex tasks required by advanced robotic systems within a unified solution.

Analysts Identify Robotics as Catalyst for NVIDIA Stock Price

Analysts at BNP Paribas, following CES, pointed to robotics as a potential catalyst for NVIDIA in 2026. They see new use cases driving demand for development and the hardware to run applications, from small IoT-connected devices to humanoid robots and large-scale industrial machinery. Compute requirements and inference workloads will also be significant drivers.

Bottlenecks in the DRAM market may ease as manufacturers shift focus from consumer memory to HBM and AI-specific products, further supporting NVIDIA's momentum in the compute stack.

Additionally, the Q4 fiscal 2026 earnings report could serve as a major catalyst. Analysts have set a high bar, forecasting year-over-year revenue growth to accelerate to over 65%. If NVIDIA maintains its current trends, it could exceed that figure and provide strong guidance, reinforcing the valuation case and bullish analyst sentiment. Analysts rate this stock a Buy, an upgrade from last year, and the consensus implies roughly a 40% upside from January support levels.

The chart suggests a catalyst could trigger a sizeable bullish surge. The late-2025 pullback cooled the market and helped define support levels heading into 2026. Although signals are still developing, indicators point toward a trend-following move higher.


 
Thank you for subscribing to The Early Bird, MarketBeat's 7:00 AM newsletter that covers stories that will impact the stock market each day.
 
This email message is a paid advertisement sent on behalf of Wide Moat Research, a third-party advertiser of The Early Bird and MarketBeat.
 
 
This ad is sent on behalf of Wide Moat Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Wide Moat Research please click here.


 
 
If you need assistance with your newsletter, don't hesitate to contact our U.S. based support team at contact@marketbeat.com.
 
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
 
Copyright 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place, Sixth Floor, Sioux Falls, South Dakota 57103-7078. United States..
 
Today's Bonus Content: Nasdaq Plans Are in Motion. Med-X Investors Are Acting Early (From Med-X)

Subscribe to receive free email updates:

0 Response to "The media won’t tell you about Trump’s new deal"

Post a Comment